News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,526 Results
Type
Article (457)
Company Profile (3)
Press Release (24066)
Section
Business (6973)
Career Advice (17)
Deals (1449)
Drug Delivery (1)
Drug Development (3440)
Employer Resources (7)
FDA (295)
Job Trends (412)
News (11748)
Policy (622)
Tag
2024 Pharm Country Digital (1)
Academia (27)
Allergies (4)
Alliances (1013)
ALS (5)
Alzheimer's disease (86)
Antibody-drug conjugate (ADC) (1)
Approvals (293)
Artificial intelligence (7)
Bankruptcy (5)
Best Places to Work (308)
Biotechnology (4)
Bladder cancer (1)
Brain cancer (2)
Breast cancer (13)
Cancer (88)
Cardiovascular disease (4)
Career advice (16)
Career pathing (1)
CAR-T (7)
Cell therapy (23)
Cervical cancer (2)
Clinical research (2868)
Collaboration (26)
Compensation (47)
COVID-19 (47)
C-suite (10)
Cystic fibrosis (5)
Data (136)
Depression (1)
Diabetes (22)
Diagnostics (259)
Diversity, equity & inclusion (2)
Drug discovery (4)
Earnings (3961)
Employer branding (3)
Employer resources (7)
Events (6712)
Executive appointments (45)
FDA (346)
Featured Employer (1)
Frontotemporal dementia (1)
Funding (26)
Gene editing (2)
Generative AI (1)
Gene therapy (8)
GLP-1 (7)
Government (44)
Guidances (3)
Healthcare (910)
IgA nephropathy (1)
Immunology and inflammation (4)
Infectious disease (50)
Inflammatory bowel disease (6)
Influenza (3)
Interviews (2)
IPO (1083)
Job creations (89)
Job search strategy (16)
Layoffs (5)
Leadership (1)
Legal (109)
Liver cancer (2)
Lung cancer (7)
Lymphoma (5)
Management (1)
Manufacturing (11)
MASH (8)
Medical device (558)
Medtech (559)
Mergers & acquisitions (439)
Metabolic disorders (42)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (111)
NextGen: Class of 2025 (105)
Non-profit (38)
Northern California (240)
Now hiring (1)
Obesity (11)
Opinion (1)
Ovarian cancer (2)
Pain (4)
Pancreatic cancer (7)
Parkinson's disease (8)
Patents (8)
Patient recruitment (5)
Peanut (1)
People (2073)
Phase I (970)
Phase II (1537)
Phase III (779)
Pipeline (90)
Postmarket research (11)
Preclinical (383)
Press Release (22)
Prostate cancer (6)
Radiopharmaceuticals (9)
Rare diseases (15)
Real estate (126)
Recruiting (3)
Regulatory (535)
Research institute (25)
Resumes & cover letters (1)
Schizophrenia (7)
Series A (3)
Series B (1)
Sickle cell disease (5)
Southern California (251)
Spinal muscular atrophy (1)
Startups (117)
Supply chain (2)
United States (1773)
Vaccines (3)
Webinars (2)
Weight loss (1)
Date
Today (7)
Last 7 days (47)
Last 30 days (185)
Last 365 days (2510)
2025 (500)
2024 (2718)
2023 (3328)
2022 (3981)
2021 (4127)
2020 (3138)
2019 (1283)
2018 (725)
2017 (848)
2016 (439)
2015 (659)
2014 (502)
2013 (335)
2012 (264)
2011 (274)
2010 (256)
Location
Africa (13)
Alabama (1)
Arizona (1)
Asia (2324)
Australia (389)
California (598)
Canada (46)
China (6)
Colorado (19)
Connecticut (2)
Europe (3286)
Florida (80)
Georgia (3)
Illinois (13)
India (1)
Indiana (19)
Iowa (1)
Japan (2)
Maryland (47)
Massachusetts (353)
Michigan (11)
Minnesota (14)
Missouri (1)
Nevada (16)
New Jersey (190)
New York (173)
North Carolina (104)
Northern California (240)
Ohio (2)
Oregon (2)
Pennsylvania (106)
Puerto Rico (1)
South America (14)
Southern California (251)
Texas (38)
Utah (15)
Washington State (11)
Wisconsin (1)
24,526 Results for "maravai lifesciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
March 18, 2025
·
24 min read
Press Releases
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
February 24, 2025
·
4 min read
Press Releases
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
January 9, 2025
·
4 min read
Press Releases
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
January 28, 2025
·
4 min read
Press Releases
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
February 25, 2025
·
4 min read
Press Releases
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
December 6, 2024
·
5 min read
Biotech Beach
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June.
May 9, 2024
·
1 min read
Press Releases
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Maravai LifeSciences Holdings, Inc., a global provider of life science reagents and services to researchers and biotech innovators, reported financial results for the first quarter ended March 31, 2024, together with other business updates.
May 8, 2024
·
19 min read
Press Releases
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
November 8, 2024
·
24 min read
Biotech Beach
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI) plans to announce its first quarter 2024 financial and operating results after the market closes on Wednesday, May 8, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
April 10, 2024
·
1 min read
1 of 2,453
Next
